I Agree

We have updated our Privacy and Cookie Policy. By clicking "I Agree" below, you acknowledge that you accept our Privacy and Cookie Policy and Terms of Use.

PLEASE TELL US A LITTLE ABOUT YOURSELF SO THAT WE CAN DISPLAY THE MOST
APPROPRIATE CONTENT TO YOU:

This site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about cookies used on Trustnet and how you can manage them, see our Privacy and Cookie Policy.

By clicking "I Agree" below, you acknowledge that you accept our Privacy Policy and Terms of Use.

For more information Click here

Login

Register

It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table
You are here: TIZIANA LIFE SC ORD 3P TILS Announcements

TIZIANA LIFE SC ORD 3P (TILS) Announcements

Date Time Source Announcement
20 Feb 2020 10:30 am
RNS
Result of GM
17 Feb 2020 7:00 am
RNS
Proposed U.S. Public Offering of ADSs
04 Feb 2020 12:00 pm
RNS
Director/PDMR Shareholding
03 Feb 2020 7:00 am
RNS
Notice of GM
23 Jan 2020 7:00 am
RNS
Filing of SEC Form F-3
21 Jan 2020 2:45 pm
RNS
Director Appointment
14 Jan 2020 11:00 am
RNS
Director/PDMR Shareholding
13 Jan 2020 7:00 am
RNS
Proposed Cancellation from AIM
09 Jan 2020 7:00 am
RNS
Further re: Foralumab Phase 1 Trial
02 Jan 2020 3:00 pm
RNS
Director/PDMR Shareholding
04 Dec 2019 7:00 am
RNS
Foralumab Phase 1 Trial
20 Nov 2019 7:00 am
RNS
Issue of Equity and Directorate Change
01 Nov 2019 7:00 am
RNS
Issue of CLN
30 Oct 2019 10:31 am
RNS
Change to ADS ratio
30 Sep 2019 7:00 am
RNS
Half-year Report
16 Sep 2019 7:00 am
RNS
Further re: Update on IND Application
10 Sep 2019 7:00 am
RNS
Phase 1 Clinical Data
04 Sep 2019 7:00 am
RNS
Phase 2a Clinical Data
21 Aug 2019 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
06 Aug 2019 7:00 am
RNS
Proposed U.S. Public Offering
22 Jul 2019 7:00 am
RNS
Phase 2a Clinical Data
01 Jul 2019 7:00 am
RNS
Teplizumab Article
28 Jun 2019 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  10:54 am
RNS
Change of Adviser
25 Jun 2019 7:00 am
RNS
Director/PDMR Shareholding
24 Jun 2019 7:00 am
RNS
Article on Clinical Activity of OKT3
11 Jun 2019 7:00 am
RNS
Director/PDMR Shareholding
07 Jun 2019 9:44 am
RNS
Director/PDMR Shareholding
03 Jun 2019 7:00 am
RNS
PDMR Dealings
31 May 2019 11:05 am
RNS
Result of AGM
28 May 2019 7:00 am
RNS
9th Annual LD Micro Invitational
07 May 2019 7:00 am
RNS
Notice of AGM
02 May 2019 7:00 am
RNS
Director/PDMR Shareholding
01 May 2019 7:00 am
RNS
Update on IND Application
25 Apr 2019 5:00 pm
RNS
Director/PDMR Shareholding
  11:06 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
24 Apr 2019 12:55 pm
RNS
Reissue: Interim Clinical Data
  7:00 am
RNS
Interim Clinical Data
15 Apr 2019 5:45 pm
RNS
Holding(s) in Company
  5:45 pm
RNS
Holding(s) in Company
  5:45 pm
RNS
Holding(s) in Company
  5:45 pm
RNS
Holding(s) in Company
  5:45 pm
RNS
Holding(s) in Company
  5:45 pm
RNS
Holding(s) in Company
04 Apr 2019 7:00 am
RNS
Final Results
20 Mar 2019 7:00 am
RNS
IND Application Submitted for NASH Oral Treatment
07 Feb 2019 7:00 am
RNS
Directorate Change
11 Dec 2018 7:00 am
RNS
Exercise of Warrants & Issue of Equity
03 Dec 2018 7:00 am
RNS
Milciclib HCC Phase IIa Trial Enrollment Completed
28 Nov 2018 7:00 am
RNS
Foralumab: Phase 1 Trial with Nasal Administration
27 Nov 2018 7:00 am
RNS
Holding(s) in Company
26 Nov 2018 7:00 am
RNS
Statement re: ADSs
23 Nov 2018 5:00 pm
RNS
Closing of Offering and Total Voting Rights
20 Nov 2018 7:30 am
RNS
Discounted exercise prices of outstanding warrants
  7:00 am
RNS
Offer Pricing, Nasdaq Listing & Loan Conversion
26 Oct 2018 5:30 pm
RNS
Issue of Equity
18 Oct 2018 7:15 am
RNS
Amended Registration Statement filed with the SEC

Top announcements

Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.

You are currently using an old browser which will not be supported by Trustnet after 31/07/2016. To ensure you benefit from all features on the site, please update your browser.   Close